Skip to main content

Share story

Science

Quantum Without the Physics book release by USC Viterbi professor

Quantum Without the Physics book release by USC Viterbi professor Image: Primary
Giacomo Nannicini, associate professor at the Daniel J. Epstein Department of Industrial and Systems Engineering, has released a book on quantum optimization. The book is titled Quantum Algorithms for Optimizers and came out in December 2025. It is written for engineers and applied mathematicians without requiring any background in quantum physics. Nannicini discussed the book in an interview with USC Viterbi writer Marc Ballon. He said the text is accessible to students and researchers with a background in optimization or applied mathematics. Knowledge of quantum mechanics is not needed to read the book. The book relies on linear algebra and computational complexity to explain quantum algorithms. Nannicini noted that this approach addresses the high barrier of entry to the field. He hopes the book will help train a new generation of scientists. Nannicini said the work highlights connections between optimization and quantum algorithms. The presentation is tailored to readers with backgrounds in applied mathematics. He is writing exercises for the book that will appear as an online companion.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from USC Viterbi and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.